Ticker
VIVSCompany Name
VIVOSIM LABS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -1.43M | -31.38% | $ 4.56M |
3/31/2025 | $ -474K | -9.94% | $ 4.77M |
12/31/2024 | $ -10.11M | -153.64% | $ 6.58M |
9/30/2024 | $ -11.83M | -191.73% | $ 6.17M |
6/30/2024 | $ -12.35M | -149.76% | $ 8.25M |
3/31/2024 | $ -14.7M | -104% | $ 14.13M |
12/31/2023 | $ -16.92M | -168.51% | $ 10.04M |
9/30/2023 | $ -16.48M | -127.75% | $ 12.9M |
6/30/2023 | $ -15.64M | -112.84% | $ 13.86M |
3/31/2023 | $ -12.8M | -84.91% | $ 15.08M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield
FCF Yield for VIVOSIM LABS INC is calculated as follows: FCF [ $ -12.78M ] / Market Cap [ $ 69.74M ]
(=) FCF Yield [ -18.33% ]
Minimum
Sep 30, 2024
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.62% |
median | 3.25% |
std | 11.36% |